J. Jac

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

Robert J. Amato, J. Jac, S. Giessinger et al. · Cancer · 2009 · 202 citations · Full text

A phase II trial of intra-patient dose-escalated sorafenib in patients (pts) with metastatic renal cell cancer (MRCC)

R. J. Amato, Patricia Harris, Martin L. Dalton et al. · Journal of Clinical Oncology · 2007 · 85 citations

Therapeutic Drug Monitoring, Intra-patient Dose-escalated Sorafenib, Urology +15

The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT)

BS Teh, C. Bloch, M Galli-Guevara et al. · Biomedical Imaging and Intervention Journal · 2007 · 77 citations · Full text

Vaccination of Renal Cell Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Alone or Administered in Combination With Interferon-α (IFN-α)

Robert J. Amato, William Shingler, Madusha Goonewardena et al. · Journal of Immunotherapy · 2009 · 76 citations

Immunology, Immunoediting, Immunodominance +21

Vaccination of Renal Cell Cancer Patients with Modified Vaccinia Ankara Delivering Tumor Antigen 5T4 (TroVax) Administered with Interleukin 2: A Phase II Trial

Robert J. Amato, William Shingler, Stuart Naylor et al. · Clinical Cancer Research · 2008 · 62 citations